A cikin garin foda da ake sha kowace rana, wanda ke ƙunshe da sinadarai 12, wani mujallar kardiology ta ba da rahoton cewa aikin jijiyoyin jini ya inganta bayan watanni shida. Wannan shi ne takaitaccen bayani game da sabon gwajin bazuwar da aka yi na NOVOS Core. Gaskiyar lamari ta fi ban sha'awa, kuma tana bukatar a duba ta da hankali fiye da yadda tallace‑tallace ke gabatar da ita.
Wannan bincike, da aka wallafa a European Heart Journal Open, gwaji ne mai ƙunshi tsarin double‑blind da aka gudanar a Jami'ar Surrey da ƙungiyoyin NHS masu alaƙa. Ga abin da aka gano, abin da ba a gano ba, da wa ya kamata ya damu.
Lambobin da Suka Fi Jan Hanya
Gwajin (wanda aka rijista a matsayin NCT06145087) ya gwada garin foda mai sinadarai da dama – bitamin, ma'adinai, amino acid, da sinadarai na tsire‑tsire – akan wani rukunin kulawa. Mahalicin ya kasance manya masu lafiya a zahiri. Dukkan siffofin da ke ƙasa suna nuni da bambanci a canjin da aka samu tsakanin ƙungiyar ƙari da ƙungiyar kulawa bayan watanni 6.
- Aikin endothelium: fadin da aka samu daga ƙara jini (FMD), babban abin da ake auna, ya inganta da 2.9 % (95 % CI 2.1 zuwa 3.8).
- Karfin jijiyoyin: saurin tafiyar da raƙuman bugun zuciya (PWV) ya ragu da 1.18 m/s (95 % CI -2.00 zuwa -0.36).
- Matsi jini na systolic: SBP ya sauka da 6.1 mmHg (95 % CI -10.9 zuwa -1.3).
- Kimar haɗarin cutar zuciya na shekaru 10: SCORE2/SCORE2‑OP ya ragu da 0.45 % (95 % CI -0.86 zuwa -0.03).
- Lipids: ba su canza ba.
FMD na auna yadda bangaren ciki na jijiyar ke sassauta yayin da aka ƙara yawan jini, kuma ana amfani da shi sosai a matsayin alamar lafiyar endothelium. PWV na auna yadda saurin raƙuman bugun zuciya ke yawo a cikin jijiyoyi; ƙaramar ƙima na nufin jijiyoyi masu sassauci. Dukkansu alamomi ne na wakilci, ba ainihin bugun zuciya ko bugun jini ba.
Abin Da Ya Banbanta: Ba Cholesterol Ba ne
Yawancin kari na “lafiyar zuciya” suna samun yabo saboda canjin lipids. Wannan ba shi ne abin da aka samu ba. Mawallafa sun danganta raguwar ƙimar haɗarin da aka kiyasta da rage matsi jini na systolic, domin lissafin SCORE2 yafi dogara kan SBP, shekaru, jinsi, shan taba, da cholesterol. Idan lipids sun tsaya a wuri guda, to matsi jini shine babban abu da zai iya juyar da sakamakon.
Raguwar haɗari ma ba ta da girma sosai a ainihi. Mahalicci sun fara da ƙimar 3.6 ± 2.9 %, don haka raguwar 0.45 % tana nufin canji ƙanana daga matakin da aka fara da shi. Wannan kiyasin ne daga kalkuleta, ba ainihin rage abubuwan da suka faru ba.
Nawa Ne Shaidar?
Wannan gwaji ne na bazuwar, double‑blind, a kan mutane, wanda ke da ƙarfi fiye da gwaje‑gwajen dabbobi ko bayanan kallo‑kallo. Amma akwai wasu iyakoki da ke rage amfanin sakamakon.
- Karami ne. An rarraba mutane 61 (33 zuwa ƙari, 28 zuwa kulawa), kuma kawai 43 ne suka kammala duka ziyarta biyu (24 vs 19). Wannan na nufin kusan kashi 30 % na mahalarta sun ƙare, wanda zai iya karkatar da sakamako idan waɗanda suka fita sun bambanta da waɗanda suka ci gaba.
- Mai tallafa yana da hannu. A cewar bayanin rikice‑ra’ayin, ɗaya daga cikin marubuta ma’aikaci ne na NOVOS Labs, kuma babbar marubucin Christian Heiss ya karɓi kuɗin bincike daga NOVOS Labs. Shiga masana’antu ba ya kawar da ingancin gwaji, amma yana ƙara buƙatar sake gwadawa da masu zaman kansu.
- Mutanen da aka yi wa gwajin suna da lafiya kuma ba su da haɗari. Sakamako a manya masu lafiya ba lallai su shafi waɗanda ke da hypertension, ciwon sukari, ko cutar zuciya da aka riga aka sani ba.
- Alamomin wakilci ne. Ingantaccen FMD da PWV alamu ne masu kyau, amma gwajin ba a tsara shi ko a ba shi ƙarfi don nuna rage yawan abubuwan da suka shafi zuciya.
- Sakamakon ya shafi duka garin. Da sinadarai 12 a haɗe, binciken ba zai iya fayyace wane ɓangare, idan akwai, ke haifar da tasirin ba.
Abin Da Wannan Ba Shi Ba
Ko da yake an kira shi “garin tsawon rai”, wannan ba sakamakon tsufa na halitta ko tsawon rai ba. Takardar na auna aikin jijiyoyi da matsi jini. Ba ta ba da rahoton agogo na epigenetic, mutuwa, ko tsawon rai ba. Marubuta sun bayyana wannan tsari a matsayin wanda ke nufin hanyoyin da suka shafi tsufar jijiyoyi, kuma wannan tunani ne game da yadda yake aiki, ba hujja ba na rage tsufa.
Abstrakt din ma ya ambaci gwajin jijiyoyi na gaggawa bayan shan ƙarin, amma manyan sakamakon da aka ba da rahoto sune tasirin watanni 6.
Abubuwan Da Za Su Iya Amfani Da Su
- Kima da lokaci: Abstrakt din ya bayyana shan yau da kullum na tsawon watanni 6 amma ba ya ba da takamaiman girman ƙwararren ko lokacin rana. Yi amfani da umarnin da ke kan alamar samfurin kuma ka duba cikakken rubutu (PMC13730552) don sanin yadda ake yi. Kada ka ɗauka cewa “ƙari yafi kyau”.
- Waɗanda za su iya sha’awa: Manyan mutane masu lafiya waɗanda suka riga sun yi abubuwan asali (aiki, abinci, bacci, rashin shan taba) kuma ke son ƙarin dabaru don lafiyar jijiyoyi. Ko da a gare su, shaida ce guda ɗaya kaɗai, wacce ke da alaka da mai tallafa.
- Waɗanda ya kamata su yi hankali ko su guje shi:
- Mutanen da ke shan maganin rage matsi jini, domin ƙarin tasirin rage matsi na iya faruwa. Wannan kariya ce gabaɗaya, ba a gwada a cikin takarda ba.
- Kowa da ke shan magungunan rubutu, masu ciki ko masu shayarwa, ko da ke da wata cuta, ya kamata ya duba jerin sinadarai tare da likita kafin ya fara.
- Kowa da ke tunanin garin zai maye gurbin statin, maganin rage matsi, ko canjin salon rayuwa. Wannan gwaji ba ya tallafa wa wannan tunani, kuma lipids ba su canza.
- Kowa da ke sa ran tasirin anti‑aging da aka tabbatar. Wannan gwaji bai gwada hakan ba.
Kammalawa
Gwajin ya ba da alamar da ke da kwarin gwiwa: garin foda mai sinadarai da yawa ya danganta da ingantaccen aikin endothelium, rage karfin jijiyoyi, da rage matsi jini na systolic a cikin manya masu lafiya, ba tare da wani canjin cholesterol ba. Amma adadin ya yi ƙanƙanta, masu halarta da yawa sun fita, kamfanin ya ba da kayan aiki da tallafi, kuma sakamakon su ne alamomin wakilci. Mataki na gaba shi ne manyan gwaje‑gwaje masu zaman kansu, na tsawon lokaci, waɗanda za su haɗa da ƙananan haɗari kuma su tantance wane sinadari ne ke da tasiri.
Tushen: PubMed 42979377 | DOI: 10.1093/ehjopen/oeag157 | Rijistar Gwaji NCT06145087
Wannan labarin na don bayanin kawai, ba shawarar likita ba.